Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

frovatriptanDecember 21 2015

Generic frovatriptan film-coated tablets are now available.


Teva launched its 2.5 mg strength film-coated tablets in packs of six, on the first day after the patent expired on the originator brand version of the medicine, Migard, made by A Menarini Farmaceutica Internazionale SRL.

Frovatriptan film-coated tablets are indicated for the acute treatment of the headache phase of migraine attacks with or without aura, says Teva. It points out that the charity, Migraine Action, estimates that one in seven people in the UK suffer from migraine and the condition costs the UK over £2 billion each year.

Paul Burden, Director, Generics, at Teva, said: “We’re pleased to be adding this medicine to our range. We hope it makes a positive impact on the lives of patients living with migraine, while also helping reduce the cost of treating this condition, which in turn helps the NHS, patients and payors.”


Teva announcement

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...